BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sivaram G, Tiwari SK, Bardia A, Manoj G, Santhosh B, Saikant R, Aejaz H, Vishnupriya S, Khan AA, Habibullah C. Association of genetic variants of mannan-binding (MBL) lectin-2 gene, MBL levels and function in ulcerative colitis and Crohn’s disease. Innate Immun. 2011;17:526-531. [PMID: 21088049 DOI: 10.1177/1753425910384531] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Ray G. Inflammatory bowel disease in India - Past, present and future. World J Gastroenterol 2016; 22(36): 8123-8136 [PMID: 27688654 DOI: 10.3748/wjg.v22.i36.8123] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
2 Butul B, Fathima N, Vishwakarma SK, Khan AA. Genetic association and epistatic interaction analysis of cluster of differentiation 14 and mannan-binding lectin 2 gene polymorphic variants in susceptibility to chronic periodontitis. Meta Gene 2021;30:100963. [DOI: 10.1016/j.mgene.2021.100963] [Reference Citation Analysis]
3 Jain U, Otley AR, Van Limbergen J, Stadnyk AW. The Complement System in Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2014;20:1628-37. [DOI: 10.1097/mib.0000000000000056] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
4 Singh H, Jadhav S, Chauware V. Impact of MBL-2 coding region polymorphism on modulation of HAND and HIV-1 acquisition. Microb Pathog 2021;160:105163. [PMID: 34480982 DOI: 10.1016/j.micpath.2021.105163] [Reference Citation Analysis]
5 Morgan BP, Harris CL. Complement, a target for therapy in inflammatory and degenerative diseases. Nat Rev Drug Discov 2015;14:857-77. [PMID: 26493766 DOI: 10.1038/nrd4657] [Cited by in Crossref: 227] [Cited by in F6Publishing: 210] [Article Influence: 32.4] [Reference Citation Analysis]
6 Walsh D, McCarthy J, O'Driscoll C, Melgar S. Pattern recognition receptors--molecular orchestrators of inflammation in inflammatory bowel disease. Cytokine Growth Factor Rev 2013;24:91-104. [PMID: 23102645 DOI: 10.1016/j.cytogfr.2012.09.003] [Cited by in Crossref: 65] [Cited by in F6Publishing: 71] [Article Influence: 6.5] [Reference Citation Analysis]
7 Jain U, Woodruff TM, Stadnyk AW. The C5a receptor antagonist PMX205 ameliorates experimentally induced colitis associated with increased IL-4 and IL-10. Br J Pharmacol 2013;168:488-501. [PMID: 22924972 DOI: 10.1111/j.1476-5381.2012.02183.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
8 Sina C, Kemper C, Derer S. The intestinal complement system in inflammatory bowel disease: Shaping intestinal barrier function. Semin Immunol. 2018;37:66-73. [PMID: 29486961 DOI: 10.1016/j.smim.2018.02.008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 10.3] [Reference Citation Analysis]